Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
- PMID: 22160507
- DOI: 10.1007/s00417-011-1883-6
Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
Comment in
-
Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy.Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):403-4. doi: 10.1007/s00417-011-1884-5. Epub 2011 Dec 6. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 22143677 No abstract available.
Comment on
-
Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1159-66. doi: 10.1007/s00417-011-1651-7. Epub 2011 Mar 30. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21448811
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
